FREE SHIPPING over $40
OVER 10000 FIVE-STAR REVIEWS
5% OFF ALL SUBSCRIPTIONS
100% HAPPINESS GUARANTEE
Analyze Diet
0
Viruses2025; 17(5); 612; doi: 10.3390/v17050612

Investigation of Selected Prevalence Factors Associated with EHV-2 and/or EHV-5 Infection in Horses with Acute Onset of Fever and Respiratory Signs.

Abstract: The purpose of this study was to determine any associations of EHV-2, EHV-5, and dual infection with EHV-2/-5 with demographic parameters, clinical signs, and coinfection with other common respiratory pathogens. Nasal swabs collected from 9737 horses were tested for EHV-2 and EHV-5, as well as EHV-1, EHV-4, EIV, , ERAV, and ERBV, by qPCR. Clinical signs and demographic parameters were recorded, and prevalence factors were evaluated for significance regarding EHV-2 and/or EHV-5 infection. Out of the 9737 horses in this study, 17.8% tested EHV-2-positive ( = 1731), 15.8% tested EHV-5-positive ( = 1536), 33.4% tested positive for both viruses EHV-2/-5 ( = 3247), and 33.1% tested negative for both viruses ( = 3223). When comparing EHV-2 and/or EHV-5 infected horses to horses testing qPCR-negative for both viruses, horses infected with EHV-2 alone were more likely to be younger Thoroughbreds with a history of recent transportation, presenting with fever, and having a higher rate of coinfections with EHV-4 and . Horses infected with EHV-5 alone were less likely to be used for pleasure purposes, had fewer clinical signs, and were more likely to be coinfected with EHV-4. Horses dually infected with EHV-2 and EHV-5 were much more likely to be younger, used for competition, presenting with a fever, and coinfected with additional respiratory pathogens. It is apparent from the study population that horses infected with EHV-2 alone or in combination with EHV-5 had breed predilections, greater frequency of clinical signs, and a higher rate of coinfections with EHV-4, ERBV, and .
Get Full Text
Publication Date: 2025-04-25 PubMed ID: 40431624PubMed Central: PMC12116073DOI: 10.3390/v17050612Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
LinkedInCopy
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

This study examined the relationship of EHV-2 and EHV-5 infections with demographic and clinical factors in horses. It found that factors such as age, breed, employment (competition or pleasure), recent transport and co-infections had a significant bearing on the prevalence of these infections.

Research methodology

  • The study aimed to identify any connections between infection with EHV-2, EHV-5, or both, and certain demographic factors, clinical indicators, and coexistence with other common respiratory pathogens.
  • Nasal swabs from 9,737 horses were examined for EHV-2, EHV-5, EHV-1, EHV-4, EIV, ERAV, and ERBV using quantitative Polymerase Chain Reaction (qPCR).
  • Various clinical signs and demographic data were noted, and prevalence factors were checked for their significance in relation to EHV-2 and/or EHV-5 infection.

Findings

  • Of the horses included, 17.8% tested positive for EHV-2, 15.8% for EHV-5, 33.4% for both viruses and 33.1% were free of both viruses.
  • Comparing the horses that tested positive for either or both viruses to those that were negative for both, revealed that horses with only EHV-2 were likely to be younger Thoroughbreds that had recently been transported and presented with fever. This group also had a high rate of co-infections with EHV-4.
  • Horses infected solely with EHV-5 were less likely to be used for pleasure riding, had fewer clinical signs, and also had a higher incidence of EHV-4 co-infection.
  • Horses infected with both EHV-2 and EHV-5 were more likely to be younger, used for competition, showing symptoms of fever, and be co-infected with other respiratory pathogens.

Conclusion

  • The research data indicates that horses with EHV-2 infection, either alone or in concert with EHV-5, had breed preferences and showed clinical signs more frequently.
  • These horses also had a higher co-infection rate with pathogens EHV-4, ERBV, and .
  • These findings suggest that demographic factors like age, breed, purpose of use and recent transportation, as well as co-infections with other respiratory pathogens, play a significant role in the susceptibility of horses to EHV-2 and EHV-5 infections.

Cite This Article

APA
James K, Chappell DE, Craig B, Pariseau C, Wright C, van Harreveld P, Barnum S, Pusterla N. (2025). Investigation of Selected Prevalence Factors Associated with EHV-2 and/or EHV-5 Infection in Horses with Acute Onset of Fever and Respiratory Signs. Viruses, 17(5), 612. https://doi.org/10.3390/v17050612

Publication

Viruses
ISSN: 1999-4915
NlmUniqueID: 101509722
Country: Switzerland
Language: English
Volume: 17
Issue: 5
PII: 612

Researcher Affiliations

James, Kaitlyn
  • Department of Obstetrics, Gynecology and Reproduction Biology, Massachusetts General Hospital, Boston, MA 02114, USA.
Chappell, Duane E
  • Merck Animal Health, Rahway, NJ 07065, USA.
Craig, Bryant
  • Merck Animal Health, Rahway, NJ 07065, USA.
Pariseau, Chrissie
  • Merck Animal Health, Rahway, NJ 07065, USA.
Wright, Cara
  • Merck Animal Health, Rahway, NJ 07065, USA.
van Harreveld, Philip
  • Merck Animal Health, Rahway, NJ 07065, USA.
Barnum, Samantha
  • Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.
Pusterla, Nicola
  • Department of Medicine and Epidemiology, School of Veterinary Medicine, University of California, Davis, CA 95616, USA.

MeSH Terms

  • Animals
  • Horses
  • Horse Diseases / virology
  • Horse Diseases / epidemiology
  • Prevalence
  • Herpesviridae Infections / veterinary
  • Herpesviridae Infections / epidemiology
  • Herpesviridae Infections / virology
  • Coinfection / veterinary
  • Coinfection / virology
  • Coinfection / epidemiology
  • Male
  • Female
  • Fever / veterinary
  • Fever / virology
  • Fever / epidemiology
  • Respiratory Tract Infections / veterinary
  • Respiratory Tract Infections / virology
  • Respiratory Tract Infections / epidemiology

Grant Funding

  • 000 / Merck Animal Health

Conflict of Interest Statement

N.P., S.B., and K.J. declare no conflicts of interest. D.E.C., B.C., C.P., C.W., and P.v.H currently work for Merck Animal Health, Rahway, NJ, USA.

References

This article includes 23 references
  1. Fortier G, van Erck E, Pronost S, Lekeux P, Thiry E. Equine gammaherpesviruses: Pathogenesis, epidemiology and diagnosis.. Vet. J. 2010;186:148–156.
    doi: 10.1016/j.tvjl.2009.08.017pubmed: 19766026google scholar: lookup
  2. Hartley CA, Dynon KJ, Mekuria ZH, El-Hage CM, Holloway SA, Gilkerson JR. Equine gammaherpesviruses: Perfect parasites?. Vet. Microbiol. 2013;167:86–92.
    doi: 10.1016/j.vetmic.2013.05.031pubmed: 23845734google scholar: lookup
  3. Bell SA, Balasuriya UBR, Gardner IA, Barry PA, Wilson WD, Ferraro GL, MacLachlan NJ. Temporal detection of equine herpesvirus infections of a cohort of mares and their foals.. Vet. Microbiol. 2006;116:249–257.
    doi: 10.1016/j.vetmic.2006.05.002pubmed: 16774810google scholar: lookup
  4. Browning GF, Studdert MJ. Epidemiology of equine herpesvirus 2 (equine cytomegalovirus). J. Clin. Microbiol. 1987;25:13–16.
    doi: 10.1128/jcm.25.1.13-16.1987pmc: PMC265802pubmed: 3025249google scholar: lookup
  5. Nordengrahn A, Rusvai M, Merza M, Ekstrom J, Morein B, Belak S. Equine herpesvirus type 2 (EHV-2) as a predisposing factor for Rhodococcus equi pneumonia in foals: Prevention of the bifactorial disease with EHV-2 immunostimulating complexes.. Vet. Microbiol. 1996;51:55–68.
    doi: 10.1016/0378-1135(96)00032-6pubmed: 8828122google scholar: lookup
  6. Purewal AS, Smallwood AV, Kaushal A, Adegboye D, Edington N. Identification and control of the cis-acting elements of the immediate early gene of equid herpesvirus type 1.. J. Gen. Virol. 1992;73:513–519.
    doi: 10.1099/0022-1317-73-3-513pubmed: 1545217google scholar: lookup
  7. Varga J, Fodor L, Rusvai M, Soos I, Makrai L. Prevention of Rhodococcus equi pneumonia of foals using two different inactivated vaccines.. Vet. Microbiol. 1997;56:205–212.
    doi: 10.1016/S0378-1135(97)00089-8pubmed: 9226835google scholar: lookup
  8. Welch HM, Bridges CG, Lyon AM, Griffiths L, Edington N. Latent equid herpesviruses 1 and 4: Detection and distinction using the polymerase chain reaction and co-cultivation from lymphoid tissues.. J. Gen. Virol. 1992;73:261–268.
    doi: 10.1099/0022-1317-73-2-261pubmed: 1347078google scholar: lookup
  9. Marenzoni ML, Passamonti F, Lepri E, Cercone M, Capomaccio S, Cappelli K, Felicetti M, Coppola G, Coletti M, Thiry E. Quantification of Equid herpesvirus 5 DNA in clinical and necropsy specimens collected from a horse with equine multinodular pulmonary fibrosis.. J. Vet. Diagn. Investig. 2011;23:802–806.
    doi: 10.1177/1040638711407890pubmed: 21908328google scholar: lookup
  10. Pusterla N, James K, Barnum S, Bain F, Barnett DC, Chappell D, Gaughan E, Craig B, Schneider C, Vaala W. Frequency of detection and prevalence factors associated with common respiratory pathogens in equids with acute onset of fever and/or respiratory signs (2008–2021). Pathogens 2022;11:759.
    doi: 10.3390/pathogens11070759pmc: PMC9317490pubmed: 35890002google scholar: lookup
  11. Pusterla N, Mapes S, Wademan C, White A, Hodzic E. Investigation of the role of lesser characterised respiratory viruses associated with upper respiratory tract infections in horses.. Vet. Rec. 2013;172:315.
    doi: 10.1136/vr.100943pubmed: 23423483google scholar: lookup
  12. Ataseven VS, Bilge-Dagalp S, Oguzoglu TC, Karapinar Z, Güzel M, Tan MT. Detection and sequence analysis of equine gammaherpesviruses from horses with respiratory tract disease in Turkey.. Transbound. Emerg. Dis. 2010;57:271–276.
    doi: 10.1111/j.1865-1682.2010.01146.xpubmed: 20553426google scholar: lookup
  13. Hue ES, Fortier GD, Fortier CI, Leon AM, Richard EA, Legrand LJ, Pronost SL. Detection and quantitation of equid gammaherpesviruses (EHV-2, EHV-5) in nasal swabs using an accredited standardised quantitative PCR method.. J. Virol. Methods. 2014;198:18–25.
    doi: 10.1016/j.jviromet.2013.12.008pubmed: 24370678google scholar: lookup
  14. Negussie H, Gizaw D, Tesfaw L, Li Y, Oguma K, Sentsui H, Tessema TS, Nauwynck HJ. Detection of equine herpesvirus (EHV) -1, -2, -4 and -5 in Ethiopian equids with and without respiratory problems and genetic characterization of EHV-2 and EHV-5 strains.. Transbound. Emerg. Dis. 2017;64:1970–1978.
    doi: 10.1111/tbed.12601pubmed: 28102009google scholar: lookup
  15. El-Hage C, Mekuria Z, Dynon K, Hartley C, McBride K, Gilkerson J. Association of equine herpesvirus 5 with mild respiratory disease in a survey of EHV1, -2, -4 and -5 in 407 Australian horses.. Animals 2021;11:3418.
    doi: 10.3390/ani11123418pmc: PMC8697987pubmed: 34944194google scholar: lookup
  16. Temesgen T, Getachew Y, Negussie H. Molecular identification of equine herpesvirus 1, 2, and 5 in equids with signs of respiratory disease in central Ethiopia.. Vet. Med. 2021;212:337–345.
    doi: 10.2147/VMRR.S339042pmc: PMC8694401pubmed: 34956854google scholar: lookup
  17. Wondimagegnehu K, Leta S, Amenu K, Negussie H. Molecular detection and assessment of the epidemiological risk factors associated with equine herpesvirus 2 and 5 in working equids in central Ethiopia.. Vet. Med. Sci. 2022;28:2396–2403.
    doi: 10.1002/vms3.925pmc: PMC9677389pubmed: 36063540google scholar: lookup
  18. Nguyen YN, McGuffie BA, Anderson VE, Weinberg JB. Gammaherpesvirus modulation of mouse adenovirus type 1 pathogenesis.. Virology 2008;380:182–190.
    doi: 10.1016/j.virol.2008.07.031pmc: PMC2577692pubmed: 18768196google scholar: lookup
  19. Schneider C, James K, Craig BW, Chappell DE, Vaala W, van Harreveld PD, Wright CA, Barnum S, Pusterla N. Characterization of equine rhinitis B virus infection in clinically ill horses in the United States during the period 2012–2023.. Pathogens 2023;12:1324.
    doi: 10.3390/pathogens12111324pmc: PMC10674924pubmed: 38003789google scholar: lookup
  20. Zhao J, Negussie H, Laval K, Poelaert KC, Nauwynck HJ. Dual infections of equine herpesvirus 1 and equine arteritis virus in equine respiratory mucosa explants.. Virus Res. 2016;220:104–111.
    doi: 10.1016/j.virusres.2016.04.013pubmed: 27117322google scholar: lookup
  21. Thorsteinsdottir L, Torfason EG, Torsteinsdottir S, Svansson V. Genetic diversity of equine gammaherpesviruses (gamma-EHV) and isolation of a syncytium forming EHV-2 strain from a horse in Iceland.. Res. Vet. Sci. 2013;294:170–177.
    doi: 10.1016/j.rvsc.2012.07.011pubmed: 22862856google scholar: lookup
  22. Back H, Ullman K, Leijon M, Soderlund R, Penell J, Stahl K, Pringle J, Valarcher JF. Genetic variation and dynamics of infections of equid herpesvirus 5 in individual horses.. J. Gen. Virol. 2016;97:169–178.
    doi: 10.1099/jgv.0.000332pubmed: 26518010google scholar: lookup
  23. Renzette N, Pokalyuk C, Gibson L, Bhattacharjee B, Schleiss MR, Hamprecht K, Yamamoto AY, Mussi-Pinhata MM, Britt WJ, Jensen JD. Limits and patterns of cytomegalovirus genomic diversity in humans.. Proc. Natl. Acad. Sci. USA. 2015;112:E4120–E4128.
    doi: 10.1073/pnas.1501880112pmc: PMC4522815pubmed: 26150505google scholar: lookup

Citations

This article has been cited 0 times.
Subscribe to our newsletter
Join 99,824 horse owners like you who receive our email updates on horse health and nutrition.